Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Igor Barjaktarevic, MD, PhD

Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Igor Barjaktarevic, MD, PhD
HS Associate Clinical Professor, Medicine. Authored (or co-authored) 191 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sanofi
- Links
- Sign up for this study
- ID
- NCT05897424
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 130 study participants
- Last Updated